Telix Pharmaceuticals has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc. The company specialises in the physics, chemistry and materials science of cyclotron-produced radionuclides. Telix expects to continue to operate and expand the company's R&D and production capabilities at the Burnaby location.